A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies

NCT00719862 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

481

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Placebo nasal spray
DRUG: 0.15% azelastine hydrochloride Nasal Spray

Sponsor

Meda Pharmaceuticals